BridgeBio Pharma, Inc. EV/Sales

EV/Sales of BBIO for past 10 years: annual, quarterly and twelve month trailing (TTM) including EV/Sales growth rates and interactive chart. Compares the total enterprise value of a company to its sales. It is a more accurate measure of business value, as it takes into account cash and debt on the balance sheet. A company with large cash holdings and no debt will show a significantly lower EV/S than P/S ratio.


Highlights and Quick Summary

Current EV/Sales of BridgeBio Pharma, Inc. is 47.3 (as of December 31, 2021)
  • EV/Sales for the quarter ending September 30, 2022 was 29.26 (a 14.02% increase compared to previous quarter)
  • Year-over-year quarterly EV/Sales decreased by -38.14%
  • Annual EV/Sales for 2021 was 47.3 (a -72.05% decrease from previous year)
  • Annual EV/Sales for 2020 was 169.25 (a Infinity% increase from previous year)
Visit stockrow.com/BBIO for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow statement with 10 years of data, and state-of-the-art screener.

Historical EV/Sales of BridgeBio Pharma, Inc.

Most recent EV/Salesof BBIO including historical data for past 10 years.

Interactive Chart of EV/Sales of BridgeBio Pharma, Inc.

BridgeBio Pharma, Inc. EV/Sales for the past 10 Years (both Annual and Quarterly)

Year Q1 Q2 Q3 Q4 Fiscal Year
2022 29.26 25.66 35.77
2021 47.3 134.75 151.23 398.81 47.3
2020 169.25 0.0 169.25
2019 0.0 0.0 0.0

Business Profile of BridgeBio Pharma, Inc.

Sector: Healthcare
Industry: Biotechnology